Authors:
Shin, DM
Donato, NJ
Perez-Soler, R
Shin, HJC
Wu, JY
Zhang, P
Lawhorn, K
Khuri, FR
Glisson, BS
Myers, J
Clayman, G
Pfister, D
Falcey, J
Waksal, H
Mendelsohn, J
Hong, WK
Citation: Dm. Shin et al., Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer, CLIN CANC R, 7(5), 2001, pp. 1204-1213
Authors:
Papadimitrakopoulou, VA
Izzo, J
Mao, L
Keck, J
Hamilton, D
Shin, DM
El-Naggar, A
den Hollander, P
Liu, D
Hittelman, WN
Hong, WK
Citation: Va. Papadimitrakopoulou et al., Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: Role in response to chemoprevention and cancer development, CLIN CANC R, 7(10), 2001, pp. 3127-3134
Authors:
Shin, DM
Charuruks, N
Lippman, SM
Lee, JJ
Ro, JY
Hong, WK
Hittelman, WN
Citation: Dm. Shin et al., p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis, CANC EPID B, 10(6), 2001, pp. 603-609
Citation: Mn. Lango et al., Targeting growth factor receptors: integration of novel therapeutics in the management of head and neck cancer, CURR OPIN O, 13(3), 2001, pp. 168-175
Authors:
Posner, MR
Glisson, B
Frenette, G
Al-Sarraf, M
Colevas, AD
Norris, CM
Seroskie, JD
Shin, DM
Olivares, R
Garay, CA
Citation: Mr. Posner et al., Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancerof the head and neck, J CL ONCOL, 19(4), 2001, pp. 1096-1104
Authors:
Shin, DM
Khuri, FR
Murphy, B
Garden, AS
Clayman, G
Francisco, M
Liu, D
Glisson, BS
Ginsberg, L
Papadimitrakopoulou, V
Myers, J
Morrison, W
Gillenwater, A
Ang, KK
Lippman, SM
Goepfert, H
Hong, WK
Citation: Dm. Shin et al., Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: Novel bioadjuvant phase II trial, J CL ONCOL, 19(12), 2001, pp. 3010-3017
Authors:
Khuri, FR
Rigas, JR
Figlin, RA
Gralla, RJ
Shin, DM
Munden, R
Fox, N
Huyghe, MR
Kean, Y
Reich, SD
Hong, WK
Citation: Fr. Khuri et al., Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer, J CL ONCOL, 19(10), 2001, pp. 2626-2637
Authors:
Kiselyov, K
Shin, DM
Shcheynikov, N
Kurosaki, T
Muallem, S
Citation: K. Kiselyov et al., Regulation of Ca2+-release-activated Ca2+ current (I-crac) by ryanodine receptors in inositol 1,4,5-trisphosphate-receptor-deficient DT40 cells, BIOCHEM J, 360, 2001, pp. 17-22
Authors:
Zhao, XS
Shin, DM
Liu, LH
Shull, GE
Muallem, S
Citation: Xs. Zhao et al., Plasticity and adaptation of Ca2+ signaling and Ca2+-dependent exocytosis in SERCA2(+/-) mice, EMBO J, 20(11), 2001, pp. 2680-2689
Citation: Sm. Kim et al., Synthesis and application of the novel azomethine metal complexes for the organic electroluminescent devices, B KOR CHEM, 22(7), 2001, pp. 743-747
Authors:
Shin, DM
Luo, X
Wilkie, TM
Miller, LJ
Peck, AB
Humphreys-Beher, MG
Muallem, S
Citation: Dm. Shin et al., Polarized expression of G protein-coupled receptors and an all-or-none discharge of Ca2+ pools at initiation sites of [Ca2+]i waves in polarized exocrine cells, J BIOL CHEM, 276(47), 2001, pp. 44146-44156
Authors:
Tseng, JE
Glisson, BS
Khuri, FR
Shin, DM
Myers, JN
El-Naggar, AK
Roach, JS
Ginsberg, LE
Thall, PF
Wang, XM
Teddy, S
Lawhorn, KN
Zentgraf, RE
Steinhaus, GD
Pluda, JM
Abbruzzese, JL
Hong, WK
Herbst, RS
Citation: Je. Tseng et al., Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck, CANCER, 92(9), 2001, pp. 2364-2373
Authors:
Shin, DM
Khuri, FR
Glisson, BS
Ginsberg, L
Papadimitrakopoulou, VM
Clayman, G
Lee, JJ
Ang, KK
Lippman, SM
Hong, WK
Citation: Dm. Shin et al., Phase II study of paclitaxel, ifosfamide, and carboplatin in patients withrecurrent or metastatic head and neck squamous cell carcinoma, CANCER, 91(7), 2001, pp. 1316-1323
Authors:
Shin, DM
Mao, L
Papadimitrakopoulou, VM
Clayman, G
El-Naggar, A
Shin, HJC
Lee, JJ
Lee, JS
Gillenwater, A
Myers, J
Lippman, SM
Hittelman, WN
Hong, WK
Citation: Dm. Shin et al., Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression, J NAT CANC, 92(1), 2000, pp. 69-73
Authors:
Tae, K
El-Naggar, AK
Yoo, E
Feng, L
Lee, JJ
Hong, WK
Hittelman, WN
Shin, DM
Citation: K. Tae et al., Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis, CLIN CANC R, 6(7), 2000, pp. 2821-2828
Authors:
Lee, JJ
Hong, WK
Hittelman, WN
Mao, L
Lotan, R
Shin, DM
Benner, SE
Xu, XC
Lee, JS
Papadimitrakopoulou, VM
Geyer, C
Perez, C
Martin, JW
El-Naggar, AK
Lippman, SM
Citation: Jj. Lee et al., Predicting cancer development in oral leukoplakia: Ten years of translational research, CLIN CANC R, 6(5), 2000, pp. 1702-1710